Cargando…
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide – with an estimated global prevalence of 37%. Different from nonalcoholic fatty liver disease (NAFLD), which is an exclusion diagnosis, MAFLD is defined by a set of positive criteria. Th...
Autores principales: | Kaya, Eda, Yilmaz, Yusuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747887/ https://www.ncbi.nlm.nih.gov/pubmed/36533185 http://dx.doi.org/10.1177/20420188221139650 |
Ejemplares similares
-
Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
por: Chandra Kumar, C. Vikneshwaran, et al.
Publicado: (2022) -
Update on genetics and epigenetics in metabolic associated fatty liver disease
por: Zhu, Xiaopeng, et al.
Publicado: (2022) -
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
por: Kulkarni, Anand V., et al.
Publicado: (2023) -
MAFLD: what 2 years of the redefinition of fatty liver disease has
taught us
por: Grabherr, Felix, et al.
Publicado: (2022) -
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique
classification considerations and challenges
por: Hegarty, Robert, et al.
Publicado: (2023)